Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 USD | +5.90% | +0.56% | -17.28% |
Mar. 21 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M | MT |
Mar. 21 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 4.64M | Sales 2025 * | 2.75M | Capitalization | 91.48M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -63M | EV / Sales 2024 * | 19.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 33.3 x |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-1.95
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.65% |
1 day | +2.34% | ||
1 week | -2.81% | ||
Current month | -38.04% | ||
1 month | -35.89% | ||
3 months | -36.67% | ||
6 months | +24.52% | ||
Current year | -20.06% |
Managers | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 23-07-10 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-25 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-02-11 | |
Joseph Patti
BRD | Director/Board Member | 60 | 19-05-08 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 21-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.68 | +5.90% | 4 014 |
24-04-25 | 2.531 | +1.23% | 4,683 |
24-04-24 | 2.5 | -1.19% | 4,871 |
24-04-23 | 2.53 | +0.80% | 16,769 |
24-04-22 | 2.51 | -5.82% | 5,098 |
Delayed Quote Nyse, April 26, 2024 at 10:39 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.06% | 91.48M | |
+2.25% | 42.59B | |
+7.61% | 40.65B | |
+48.83% | 40.57B | |
-11.96% | 26.77B | |
+8.64% | 24.81B | |
-23.86% | 18.17B | |
+28.06% | 12.05B | |
-2.69% | 11.7B | |
+6.98% | 11.1B |
- Stock Market
- Equities
- ARMP Stock